MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blaxall, H. S.
Right arrow Articles by Bylund, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaxall, H. S.
Right arrow Articles by Bylund, D. B.

Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line

HS Blaxall, DR Cerutis, NA Hass, LJ Iversen and DB Bylund

Department of Pharmacology, University of Nebraska Medical Center, Omaha 68198-6260.

The alpha 2-adrenergic receptors have been divided into four pharmacological subtypes, alpha 2A, alpha 2B, alpha 2C, and alpha 2D. The OK cell line, a cell line derived from an opossum kidney, expresses the alpha 2C-adrenergic receptor and is the prototypical cell line for the alpha 2C receptor subtype. The cloned human alpha 2C-C4 and rat RG10 receptors have been shown to express alpha 2C pharmacology. Here we report the cloning and expression of the OK alpha 2C-adrenergic receptor, OKc2. The receptor has 64% deduced amino acid identity and 21% similarity to the alpha 2-C4 receptor, giving an overall similarity of 85%. The clone, expressed in Chinese hamster ovary cells, has a pharmacology that correlates very well (r = 0.97) with that of the native OK cell alpha 2C-adrenergic receptor, and it is negatively coupled to adenylyl cyclase.

Volume 45, Issue 2, pp. 176-181, 02/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol Biol EvolHome page
J. O. Ruuskanen, H. Xhaard, A. Marjamaki, E. Salaneck, T. Salminen, Y.-L. Yan, J. H. Postlethwait, M. S. Johnson, D. Larhammar, and M. Scheinin
Identification of Duplicated Fourth {alpha}2-Adrenergic Receptor Subtype by Cloning and Mapping of Five Receptor Genes in Zebrafish
Mol. Biol. Evol., January 1, 2004; 21(1): 14 - 28.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. M. C. Lembo, M. H. Ghahremani, and P. R. Albert
Receptor Selectivity of the Cloned Opossum G Protein-Coupled Receptor Kinase 2 (GRK2) in Intact Opossum Kidney Cells: Role in Desensitization of Endogenous {alpha}2C-Adrenergic but Not Serotonin 1B Receptors
Mol. Endocrinol., January 1, 1999; 13(1): 138 - 147.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Drain, L. Li, and J. Wang
KATP channel inhibition by ATP requires distinct functional domains of the cytoplasmic C terminus of the pore-forming subunit
PNAS, November 10, 1998; 95(23): 13953 - 13958.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Arimitsu, M. Mitsui-Saito, K. Sato, H. Ozaki, Y. Koga, and H. Karaki
Mechanism of Relaxant Effect of Clonidine in Isolated Bovine Tracheal Smooth Muscle
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 681 - 687.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. Marjamäki, M. Pihlavisto, V. Cockcroft, P. Heinonen, J.-M. Savola, and M. Scheinin
Chloroethylclonidine Binds Irreversibly to Exposed Cysteines in the Fifth Membrane-Spanning Domain of the Human alpha 2A-Adrenergic Receptor
Mol. Pharmacol., March 1, 1998; 53(3): 370 - 376.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Pak, B. F. O'Dowd, and S. R. George
Agonist-induced Desensitization of the µ Opioid Receptor Is Determined by Threonine 394 Preceded by Acidic Amino Acids in the COOH-terminal Tail
J. Biol. Chem., October 3, 1997; 272(40): 24961 - 24965.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. B. Bylund, L. J. Iversen, W. J. Matulka, and D. M. Chacko

J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1171 - 1177.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Schaak, C. Cayla, R. Blaise, F. Quinchon, and H. Paris
HepG2 and SK-N-MC: Two Human Models to Study Alpha-2 Adrenergic Receptors of the Alpha-2C Subtype
J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 983 - 991.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. G. Eason, S. P. Moreira, and S. B. Liggett
Four Consecutive Serines in the Third Intracellular Loop Are the Sites for beta-Adrenergic Receptor Kinase-mediated Phosphorylation and Desensitization of the alpha[IMAGE]-Adrenergic Receptor
J. Biol. Chem., March 3, 1995; 270(9): 4681 - 4688.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Ogimoto, G. A. Yudowski, C. J. Barker, M. Kohler, A. I. Katz, E. Feraille, C. H. Pedemonte, P.-O. Berggren, and A. M. Bertorello
G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin
PNAS, March 28, 2000; 97(7): 3242 - 3247.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics